To view book detail click here
Drug Injury: Liability, Analysis, and Prevention
By James T. O’Donnell / By Gopi Doctor Ahuja
Excerpt: A woman in her late forties was placed on Prozac in October, 1997. The dosage was reduced when she experienced unspecified negative side-effects. The dosage was later inceased when the patient advised her doctor that the drug was not working. The decedent stopped using the drug in Sept, 1998. Whether this was at the direction of her doctor was not indicated.
Then she resumed using it in April, 1999. She committed suicide on May 28, 1999. The plaintiff alleged that Prozac posed a risk of violent or suicidal behavior; causes emotonal blunting and disinhibition; can cause manic or psychotic behavior and can also cause delusions and hallucinations.
The plaintiff claimed that the drug manufacturer failed to properly test the drug, failed to adequately warn of potential negative side effects, and over-promoted the drug to doctors. The case settled for a confidential amount.
Randy Nielson et al as heirs of Penny Ann Nielson, vs. Eli Lilly Company, U.S. District Court, District of Utah, Case 01, CV 446.